Seizert Capital Partners’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-18,274
Closed -$126K 218
2020
Q3
$126K Sell
18,274
-4,434
-20% -$29.1K 0.01% 186
2020
Q2
$148K Buy
+22,708
New +$147K 0.01% 195
2019
Q1
Sell
-37,903
Closed -$437K 241
2018
Q4
$437K Hold
37,903
0.02% 164
2018
Q3
$821K Buy
37,903
+15,519
+69% +$294K 0.03% 140
2018
Q2
$422K Hold
22,384
0.02% 171
2018
Q1
$422K Hold
22,384
0.02% 171
2017
Q4
$389K Buy
+22,384
New +$309K 0.01% 161

Other funds holding ARA

Seizert Capital Partners's ARA Position: Q4 2020 in Review

Seizert Capital Partners sold out of American Renal Associates Holdings, Inc (ARA) in Q4 2020, closing a stake of 18,274 shares — an estimated $126K sold.

Seizert Capital Partners first reported a position in ARA in Q4 2017 and held it in 7 quarters. The position peaked at $821K in Q3 2018. 67 funds tracked by Wall St. Rank hold ARA as of Q4 2020.

  • Seizert Capital Partners reported no remaining American Renal Associates Holdings, Inc position as of Q4 2020 after selling out during the quarter.
  • Seizert Capital Partners sold 18,274 American Renal Associates Holdings, Inc shares in Q4 2020, an estimated $126K.
  • Seizert Capital Partners first reported a position in American Renal Associates Holdings, Inc in Q4 2017 and held it in 7 quarters.
  • Seizert Capital Partners's American Renal Associates Holdings, Inc position peaked at $821K in Q3 2018.
  • 67 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q4 2020.

Based on Seizert Capital Partners's 13F filing for Q4 2020, filed 8 Feb 2021.